AstraZeneca Plc’s breast cancer pill won approval from the US Food and Drug Administration, according to Bloomberg.
The decision is a win for AstraZeneca after the agency’s advisory panel previously voted against the medicine.
Article
GEOPOLITICS | FDA Approves AstraZeneca Breast Cancer Pill
--・
Avertissement : ce contenu inclut des opinions de tiers. Il ne constitue pas un conseil. Binance Ai peut être utilisée, sans garantie de résultat. Consultez les CG.
AZNUS-0,09%